Michael Moore - 17 Jan 2023 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
President
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol
VMD
Transactions as of
17 Jan 2023
Net transactions value
-$73,737
Form type
4
Filing time
18 Jan 2023, 18:01:11 UTC
Previous filing
10 May 2022
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +9,490 +0.53% 1,815,299 18 Jan 2023 Direct F1
transaction VMD Common Shares Disposed to Issuer $73,737 -9,490 -0.52% $7.77 1,805,809 18 Jan 2023 Direct
transaction VMD Common Shares Options Exercise +18,979 +1.1% 1,824,788 18 Jan 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Phantom Share Units Options Exercise $0 -9,490 -33% $0.000000 18,978 18 Jan 2023 Common Shares 9,490 Direct F1, F3
transaction VMD Restricted Stock Units Options Exercise $0 -18,979 -33% $0.000000 37,958 18 Jan 2023 Common Shares 18,979 Direct F2, F4
transaction VMD Phantom Share Units Award $0 +20,205 $0.000000 20,205 17 Jan 2023 Common Shares 20,205 Direct F5, F6
transaction VMD Restricted Stock Units Award $0 +80,818 $0.000000 80,818 17 Jan 2023 Common Shares 80,818 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F3 Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F4 Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F5 Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F6 Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7 Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

Exhibit List: -Exhibit 24 Limited Power of Attorney